Literature DB >> 28639240

Approach to thyroid carcinoma in pregnancy.

Cristina Modesti1, Paola Aceto2, Lucia Masini3, Celestino Pio Lombardi4, Rocco Bellantone4, Liliana Sollazzi2.   

Abstract

Thyroid carcinoma is the first cancer found in general population and the second diagnosed during pregnancy following the breast one. Diagnostic and therapeutic approaches to thyroid malignancy in pregnant women pose several and serious issues to the physicians. Even if there is no consensus about the surgical treatment of thyroid carcinomas during pregnancy, a large number of women undergo surgery over the world. The best surgical and anesthesiological treatment should be chosen after reaching a consensus between surgeons, anesthesiologists, obstetrics, and the patients. From 2000 to 2016, 18 pregnant patients underwent thyroidectomy under local anesthesia (cervical plexus block) combined with conscious sedation using benzodiazepines and opiates with ultrashort duration of action. Our 15-year experience on the thyroidectomies performed using the cervical plexus block combined with conscious sedation confirms that this combined technique offers a safe chance to defeat cancer also during pregnancy. Application of hypnosis could be an interesting alternative approach to pharmacological sedation in patients who would avoid intravenous drugs.

Entities:  

Keywords:  Differentiated thyroid cancers (DTC); Local anesthesia; Pregnancy; Thyroidectomy

Mesh:

Year:  2017        PMID: 28639240     DOI: 10.1007/s13304-017-0476-2

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  15 in total

1.  Clinical guidelines for management of thyroid nodule and cancer during pregnancy.

Authors:  Juan Carlos Galofré; Garcilaso Riesco-Eizaguirre; Cristina Alvarez-Escolá
Journal:  Endocrinol Nutr       Date:  2013-10-28

2.  Cancer in pregnancy: maternal-fetal conflict.

Authors:  F S Oduncu; R Kimmig; H Hepp; B Emmerich
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-18       Impact factor: 4.553

3.  The gene encoding the common alpha subunit of the four human glycoprotein hormones.

Authors:  J C Fiddes; H M Goodman
Journal:  J Mol Appl Genet       Date:  1981

4.  Approach to the pregnant patient with thyroid cancer.

Authors:  Ernest L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  2011-02       Impact factor: 5.958

5.  Recurrent laryngeal nerve management in thyroid surgery: consequences of routine visualization, application of intermittent, standardized and continuous nerve monitoring.

Authors:  Angkoon Anuwong; Matteo Lavazza; Hoon Yub Kim; Che-Wei Wu; Stefano Rausei; Vincenzo Pappalardo; Cesare Carlo Ferrari; Davide Inversini; Andrea Leotta; Antonio Biondi; Feng-Yu Chiang; Gianlorenzo Dionigi
Journal:  Updates Surg       Date:  2016-09-20

6.  Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline.

Authors:  Marcos Abalovich; Nobuyuki Amino; Linda A Barbour; Rhoda H Cobin; Leslie J De Groot; Daniel Glinoer; Susan J Mandel; Alex Stagnaro-Green
Journal:  J Clin Endocrinol Metab       Date:  2007-08       Impact factor: 5.958

7.  Cancer associated with obstetric delivery: results of linkage with the California cancer registry.

Authors:  Lloyd H Smith; Beate Danielsen; Mark E Allen; Rosemary Cress
Journal:  Am J Obstet Gynecol       Date:  2003-10       Impact factor: 8.661

8.  Prognosis of thyroid cancer related to pregnancy: a systematic review.

Authors:  Gustavo Vasconcelos Alves; Ana Paula Santin; Tania Weber Furlanetto
Journal:  J Thyroid Res       Date:  2011-07-27

Review 9.  A review on thyroid cancer during pregnancy: Multitasking is required.

Authors:  Hussein Khaled; Nasr Al Lahloubi; Noha Rashad
Journal:  J Adv Res       Date:  2016-03-02       Impact factor: 10.479

10.  Maternal thyroid hormones are transcriptionally active during embryo-foetal development: results from a novel transgenic mouse model.

Authors:  Carmelo Nucera; Patrizia Muzzi; Cecilia Tiveron; Antonella Farsetti; Federico La Regina; Benedetta Foglio; Shou-Ching Shih; Fabiola Moretti; Linda Della Pietra; Francesca Mancini; Ada Sacchi; Francesco Trimarchi; Alessandro Vercelli; Alfredo Pontecorvi
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.